Search research articles
Contact Us
Filters
Showing results (91-100 of 164) with videos related to
Page
of 17
Sort By:
Molecular Pharmaceutics
|
December 5, 2009
Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers
Xueming Wu, Eun-Kee Jeong, Lyska Emerson, et al.
Molecular Pharmaceutics
|
October 5, 2017
Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer
Yajuan Li, Zheng Han, Sarah Roelle, et al.
Pharmaceutical Research
|
June 22, 2011
Ocular pharmacokinetic study using T₁ mapping and Gd-chelate- labeled polymers
Xianfeng Shi, Xin Liu, Xueming Wu, et al.
Molecular Pharmaceutics
|
May 21, 2010
An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix
Mingqian Tan, Xueming Wu, Eun-Kee Jeong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 25, 2006
Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes
Yuda Zong, Junyu Guo, Tianyi Ke, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
August 28, 2007
In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent
Rongzuo Xu, Yanli Wang, Xuli Wang, et al.
International Journal of Nanomedicine
|
August 29, 2007
RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping
Tianyi Ke, Eun-Kee Jeong, Xuli Wang, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
September 25, 2014
Peptide targeted high-resolution molecular imaging of prostate cancer with MRI
Xueming Wu, Guanping Yu, Daniel Lindner, et al.
Molecular Pharmaceutics
|
October 3, 2006
Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model
Thanh D Nguyen, Pascal Spincemaille, Anagha Vaidya, et al.
Cancer Communications (London, England)
|
March 20, 2020
Role of eIF4E on epithelial-mesenchymal transition, invasion, and chemoresistance of prostate cancer cells
Xujie Liu, Amita M Vaidya, Da Sun, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 164) with videos related to
Sort By:
Page
of 17
Molecular Pharmaceutics
|
December 5, 2009
Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers
Xueming Wu, Eun-Kee Jeong, Lyska Emerson, et al.
Molecular Pharmaceutics
|
October 5, 2017
Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer
Yajuan Li, Zheng Han, Sarah Roelle, et al.
Pharmaceutical Research
|
June 22, 2011
Ocular pharmacokinetic study using T₁ mapping and Gd-chelate- labeled polymers
Xianfeng Shi, Xin Liu, Xueming Wu, et al.
Molecular Pharmaceutics
|
May 21, 2010
An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix
Mingqian Tan, Xueming Wu, Eun-Kee Jeong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 25, 2006
Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes
Yuda Zong, Junyu Guo, Tianyi Ke, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
August 28, 2007
In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent
Rongzuo Xu, Yanli Wang, Xuli Wang, et al.
International Journal of Nanomedicine
|
August 29, 2007
RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping
Tianyi Ke, Eun-Kee Jeong, Xuli Wang, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
September 25, 2014
Peptide targeted high-resolution molecular imaging of prostate cancer with MRI
Xueming Wu, Guanping Yu, Daniel Lindner, et al.
Molecular Pharmaceutics
|
October 3, 2006
Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model
Thanh D Nguyen, Pascal Spincemaille, Anagha Vaidya, et al.
Cancer Communications (London, England)
|
March 20, 2020
Role of eIF4E on epithelial-mesenchymal transition, invasion, and chemoresistance of prostate cancer cells
Xujie Liu, Amita M Vaidya, Da Sun, et al.
Page
of 17